Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis

Current Therapeutic Research - Clinical and Experimental

Volumn 70, Issue 4, 2009, Pages 299-315

  Dirlik, Musa ^a   Karahan, Aydin ^a   Canbaz, Hakan ^a   Caglikulekci, Mehmet ^a   Polat, Ayşe ^a   Tamer, Lulufer ^a   Aydin, Suha ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

caspase 3; lipid peroxidation; liver injury; nuclear factor B; sulfasalazine

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER INJURY; LIVER NECROSIS; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS;

EID: 70249123079     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2009.08.005     Document Type: Article

References (52)

1. Greig J.D., Krukowski Z.H., and Matheson N.A. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 75 (1988) 216-219
2. Tracy Jr. T.F., and Fox E.S. Molecular and cellular control points in pediatric liver injury and repair. Semin Pediatr Surg. 5 (1996) 175-181
3. Miyoshi H., Rust C., Roberts P.J., et al. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117 (1999) 669-677
4. Miyoshi H., Rust C., Guicciardi M.E., and Gores G.J. NF-κB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 158 (2001) 967-975
5. Lechner A.J., Velasquez A., Knudsen K.R., et al. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med. 157 (1998) 1550-1558
6. Liu T.Z., Lee K.T., Chern C.L., et al. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappa B. Ann Clin Lab Sci. 31 (2001) 383-390
7. Jolobe O.M. Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice. Br J Surg. 84 (1997) 1747
8. Arriero M.M., López-Farré A., Fryeiro O., et al. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells. Surgery 129 (2001) 255-266
9. Moazzam F.N., Brems J.J., Yong S.L., et al. Endotoxin potentiates hepatocyte apoptosis in cholestasis. J Am Coll Surg. 194 (2002) 731-739
10. Ito Y., Machen N.W., Urbaschek R., and McCuskey R.S. Biliary obstruction exacerbates the hepatic microvascular inflammatory response to endotoxin. Shock. 14 (2000) 599-604
11. Houdijk A.P., van Lambalgen A.A., Thijs L.G., and van Leeuwen P.A. Gut endotoxin restriction improves postoperative hemodynamics in the bile duct-ligated rat. Shock. 9 (1998) 282-288
12. Regan M.C., Keane R.M., Little D., and Bouchier-Hayes D. Postoperative immunological function and jaundice. Br J Surg. 81 (1994) 271-273
13. Scott-Conner C.E., and Grogan J.B. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res. 57 (1994) 316-336
14. Saito J.M., and Maher J.J. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 118 (2000) 1157-1168
15. Plusa S., Webster N., and Primrose J. Obstructive jaundice causes reduced expression of polymor-phonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro. Gut. 38 (1996) 784-787
16. Sheen-Chen S.M., Chau P., and Harris H.W. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J Surg Res. 80 (1998) 205-209
17. Shimizu Y., Miyazaki M., Ito H., et al. Enhanced endothelial cell injury by activated neutrophils in patients with obstructive jaundice. J Hepatol. 27 (1997) 803-809
18. Christman J.W., Lancaster L.H., and Blackwell T.S. Nuclear factor kappa B: A pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med. 24 (1998) 1131-1138
19. Casini A., Ceni E., Salzano R., et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthases in human hepatic stellate cells: Role of nitric oxide. Hepatology. 25 (1997) 361-367
20. Szabó C., Cuzzocrea S., Zingarelli B., et al. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest. 100 (1997) 723-735
21. Szabo C., and Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischemia-reperfusion. Trends Pharmacol Sci. 19 (1998) 287-298
22. Krähenbühl S., Talos C., Lauterburg B.H., and Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 22 (1995) 607-612
23. Parola M., Leonarduzzi G., Robino G., et al. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med. 20 (1996) 351-359
24. Alptekin N., Mehmetçik G., Uysal M., and Aykacç-toker G. Evidence for oxidative stress in the hepatic mitochondria of bile duct ligated rats. Pharmacol Res. 36 (1997) 243-247
25. Tsai L.Y., Lee K.T., and Liu T.Z. Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats. Free Radic Biol Med. 24 (1998) 732-737
26. Wahl C., Liptay S., Adler G., and Schmid R.M. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 101 (1998) 1163-1174
27. Aruoma O.I., Wasil M., Halliwell B., et al. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effect?. Biochem Pharmacol. 36 (1987) 3739-3742
28. Demirbilek S., Akin M., Gürünlüoglu K., et al. The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats. Pediatr Surg Int. 22 (2006) 655-663
29. Turkish Republic Organic Law. Code number 5199: Animal experiments; Rule 9 [in Turkish]. http://www.cevreorman.gov.tr/yasa/k/25509.doc Accessed August 1, 2009
30. Lee E. The effect of obstructive jaundice on the migration of reticulo-endothelial cells and fibroblasts into early experimental granulomata. Br J Surg. 59 (1972) 875-877
31. Yagi K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D. (Ed). Free Radicals in Diagnostic Medicine (1994), Plenum Press, New York, NY 1-15
32. In: Golowich S.P., and Kaplan S.D. (Eds). Methods in Enzymology Vol II (1955), Academic Press, New York, NY 769
33. Tsimoyiannis E.C., Moutesidou K.J., Moschos C.M., et al. Trimetazidine for prevention of hepatic injury induced by ischaemia and reperfusion in rats. Eur J Surg. 159 (1993) 89-93
34. Lesnikova I., Lidang M., Hamilton-Dutoit S., and Koch J. pl6 as a diagnostic marker of cervical neoplasia: A tissue microarray study of 796 archival specimens. Diagn Pathol. 4 (2009) 22
35. Naito Y., Takagi T., Uchiyama K., Handa O., et al. Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats. Redox Rep. 7 (2002) 294-299
36. Barnes P.J. Nuclear factor-kappa B. Int J Biochem Cell Biol. 29 (1997) 867-870
37. Faubion W.A., Guicciardi M.E., Miyoshi H., et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest. 103 (1999) 137-145
38. Patel T., Roberts L.R., Jones B.A., and Gores G.J. Dysregulation of apoptosis as a mechanism of liver disease: An overview. Semin Liver Dis. 18 (1998) 105-114
39. Patel T., Bronk S.F., and Gores G.J. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest. 94 (1994) 2183-2192
40. Parks D.J., Blanchard S.G., Bledsoe R.K., et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science. 284 (1999) 1365-1368
41. Misra S., Ujházy P., Gatmaitan Z., et al. The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver. J Biol Chem. 273 (1998) 26638-26644
42. Yao R., and Cooper G.M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267 (1995) 2003-2006
43. Aldana P.R., Goerke M.E., Carr S.C., and Tracy Jr. T.F. The expression of regenerative growth factors in chronic liver injury and repair. J Surg Res. 57 (1994) 711-717
44. Fox E.S., Kim J.C., and Tracy T.F. NF-kappaB activation and modulation in hepatic macrophages during cholestatic injury. J Surg Res. 72 (1997) 129-134
45. Koeppel T.A., Trauner M., Baas J.C., et al. Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology 26 (1997) 1085-1091
46. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
47. Singh S., Shackleton G., Ah-Sing E., et al. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 103 (1992) 1625-1629
48. Reynolds J.V., Murchan P., Redmond H.P., et al. Failure of macrophage activation in experimental obstructive jaundice: Association with bacterial translocation. Br J Surg. 82 (1995) 534-538
49. Lin A., and Karin M. NF-kappaB in cancer: A marked target. Semin Cancer Biol. 13 (2003) 107-114
50. Weikert L.F., and Bernard G.R. Pharmacotherapy of sepsis. Clin Chest Med. 17 (1996) 289-305
51. Christman J.W., Holden E.P., and Blackwell T.S. Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med. 23 (1995) 955-963
52. Liptay S., Fulda S., Schanbacher M., et al. Molecular mechanisms of sulfasalazine-induced T-cell apoptosis. Br J Pharmacol. 137 (2002) 608-620